GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...
FierceBiotech8d
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...
Honolulu Star-Advertiser13d
Pharma company reaches $2.2B settlement in Zantac lawsuits
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...
GlobalData on MSN8d
Boehringer partners WHO Foundation to advance healthcare access
Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Hosted on MSN27d
Boehringer Ingelheim opens $66.8m new cancer research facility
Boehringer Ingelheim has opened a €60m ($66.8m) research building in Vienna, Austria, as the company looks to double down in the oncology therapeutics space. The building is named after Angelika ...
pharmaphorum5d
Boehringer says R&D pipeline is the best in its long history
Boehringer Ingelheim says it is on track to launch ... R&D pipeline that it says is the best in its 139-year history. The company expects to start around 10 new phase 2 and 3 trials within the ...
Pharmabiz13d
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...
Pharmabiz8d
Boehringer Ingelheim & WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, pledged USD 5 million to advance access to quality healthcare services for ...
Pharmaceutical Technology14d
Boehringer and Circle Pharma link to develop new cancer treatment
Boehringer Ingelheim and Circle Pharma have signed a partnership and licence agreement focused on developing a new cancer ...
Asia One9d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
2024 Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO ...
Morningstar9d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Ottumwa Courier9d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...